7:00am
Registration/Coffee/Visit Exhibits
7:30-8:10
Coffee and Case Vignettes
Drs. Greenberg, Bhatia, Narezkina and Wilkinson
8:20-9:20
PRODUCT THEATRE I - Breakfast Session - Non-CME
A Near-Complete TTR Stabilizer Intentionally Designed for Patients With ATTR-CM
Speaker: Marcus Anthony (Tony) Urey, MD
Sponsored by: BridgeBio
9:20
Visit Exhibits
9:30
Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium
Barry Greenberg, MD
SESSION I - The Cardiorenal Liver Metabolic Axis
Pam Taub, MD (Moderator)
9:40-10:00
FEATURED LECTURE I
The Cardiometabolic-Kidney-Liver Syndrome
Pam Taub, MD, FACC
10:00-10:20
GLP-1 Agonists for Treating Obesity and CV Disease
Harpreet Bhatia, MD
10:20-10:40
Novel Approaches for Optimizing Therapy of Dyslipidemia to Reduce CV Risk
Michael Wilkinson, MD
10:40-11:00
Reducing the Risk of Cardiovascular-Kidney Disease with Finerenone
Barry Greenberg, MD
11:00-11:20
Cardiometabolic Disease in Transplant Patients
Antoinette Birs, MD
11:20-11:40
Identifying and Treating Chemotherapy Induced Cardiac Disease
Anya Narezkina, MD
11:40-12:00
Update on Treating Patients with Aortic Stenosis
Gary Ma, MD
12:00-12:20
Audience Q/A
Pam Taub, MD (Moderator)
Drs. Bhatia, Wilkinson, Greenberg, Birs, Narezkina, Ma and Andrew Willeford, PharmD (Panelists)
12:20
Visit Exhibits
12:30-1:30
PRODUCT THEATRE II - Lunch Session - Non-CME
Introduction to AMVUTTRA® (vutrisiran)
Rola Khedraki, MD
Supported by: Alnylam
1:30
Visit Exhibits
Session II - Advances in Treating HFpEF, PAH and Amyloidosis
Marcus Anthony (Tony) Urey, MD (Moderator)
1:45-2:05
Advances in Managing Patients with HFpEF
Hilary Shapiro, MD
2:05-2:25
Defining and Treatment Pulmonary Arterial Hypertension (PAH) in 2025: What’s the Best Approach?
Nick H. Kim, MD
2:25-2:45
Diagnosing and Treating Amyloidosis: How Do the Experts Do It?
Marcus Anthony (Tony) Urey, MD
2:45
Coffee Break/Visit Exhibits
Session III - Hypertrophic Cardiomyopathy
Jorge Silva Enciso, MD (Moderator)
3:00-3:20
Imaging the Heart to Identify Patients with HCM and Define Risk of Future Events
Albert Hsaio, MD
3:20-3:40
Myosin Inhibitors and Other Novel Approaches for Treating Hypertrophic Cardiomyopathy
Jorge Silva Enciso, MD
3:40-4:00
Gene Therapy for HCM
Barry Greenberg, MD
4:00-4:15
Patient Perspective
HCM Patient - TBD
4:15-4:45
Case Presentation/Audience Participation
Tony Urey (Moderator)
Drs. Shapiro, Silva Enciso, Hsaio, Greenberg, TBD (Panelists)
4:45
Adjourn Day 1
7:00am
Registration Opens
7:30-8:10
Coffee and Case Vignettes
Drs. Greenberg, Wettersten, Elkayam, Heywood
8:20-9:20
PRODUCT THEATRE III - Breakfast Session - Non-CME
Rethinking Hyperkalemia Management in Patients on RAASi Therapy
Speaker: Vicky Kuo, PharmD, BCTXP
Sponsored by: AstraZeneca
9:30
Welcome and Introduction to the 31st Annual San Diego Summer Heart Failure Symposium - Day 2
Barry Greenberg, MD
Session IV - Managing Patients with Heart Failure
Barry Greenberg, MD (Moderator)
9:40-10:10
11th Annual Stanley Lloyd, MD Lecture
Improving the Quality of Care and Outcomes for Heart Failure
Gregg Fonarow, MD
10:10-10:30
Managing Social Determinants That Predispose Patients to Heart Failure
Cheryl Anderson, PhD
10:30-10:45
Selecting Additional Guideline Recommended Therapies That Improve Outcomes
Uri Elkayam, MD
10:45-11:00
Remote Monitoring Using Wearable and Implantable Devices
J Thomas Heywood, MD, FACC
11:00-11:15
New Diuretic Options for Managing Volume Overload
Nicholas Wettersten, MD
11:15-11:30
Cardiac Contractility Modulation
Farshad Raissi, MD
11:30-11:45
Living with Heart Failure: A Patient’s Perspective
Rhonda Monroe
11:45-12:10
Case Presentation and Panel Discussion with Audience Participation
Antoinette Birs, MD (Presenter)
Drs Fonarow, Anderson, Heywood, Elkayam, Wettersten, Raissi, Trina Huynh, PharmD and Rhonda Monroe (Panelists)
12:10
Visit Exhibits
12:20-1:20
PRODUCT THEATRE IV - Lunch Session - Non-CME
hATTR Progression: Addressing Polyneuropathy
Rajeev Mohan, MD
Supported by: AstraZeneca
1:20
Visit Exhibits
1:20-1:45
FOUNDERS LECTURE
Heart Failure - Looking Back and Looking Forward: A 100 year Perspective
Clyde Yancy, MD
Session V - Atrial Fibrillation/Preventing Sudden Cardiac Death/Genetics and Gene Therapy
Kimberly Hong, MD (Moderator)
1:45-2:00
Atrial Fibrillation: Rhythm vs Rate Control? Anticoagulation vs LAA Occlusion?
Jonathan Hsu, MD
2:00-2:15
Preventing Sudden Cardiac Death; Role of Wearable Devices and New ICDs
Fred Han, MD
2:15-2:30
Evaluating and Counseling Patients (and Their Families) with Suspected Genetic Cardiomyopathy
Kimberly Hong, MD
2:30-2:45
Advances in Gene Therapy for Patients with Cardiomyopathy
Barry Greenberg, MD
2:45
Coffee Break/Visit Exhibits
Session VI - Catheter Based Interventions, Shock and Management of Advanced Heart Failure
Hao (Howie) Tran, MD (Moderator)
3:00-3:15
Catheter Based Interventions for Mitral and Tricuspid Valve Disease
Ryan Reeves, MD
3:15-3:30
Recognition and Treatment of Cardiogenic Shock
Hao (Howie) Tran, MD
3:30-3:45
Use of Percutaneous Support Devices to Treat Patients with Shock
Rola Khedraki, MD
3:45-4:00
FEATURED LECTURE II
What’s New in Cardiac Transplant
Marcus Anthony (Tony) Urey, MD
4:00-4:15
Improving Outcomes with LVADs
Mark Kearns, MD
4:15-4:30
Heart Transplant: A Patient Perspective
Speaker TBD
4:30-4:50
Panel Discussion
Dr Howie Tran (Moderator)
Drs. Yancy, Hong, Greenberg, Urey, Khedraki, Kearns, Meghan Philbrick PA, Jade Kozach PharmD (Panelists)
4:50
Adjourn Until 2026 For the 32nd Annual Summer Symposium